Glaukos (GKOS) hit a new all-time high on Thursday of $183.40, buoyed by Q2 financial results that beat on both lines and increasing its full-year revenue guidance.
The ophthalmic company now sees 2026 revenue of $680M-$700M, up from $620M-$635M prior
Consensus is $686.24M. To ensure this doesnât happen in the future, please enable Javascript and cookies in your browser